B BIOTICARE
DEAD

Serial Number

98657956

Owner

Caelus Pharmaceuticals B.V.

Attorney

Kelley S. Gordon

Filing Date

Jul 19, 2024

Add to watchlist:

No watchlists yet
View on USPTO

B BIOTICARE Trademark

Serial Number: 98657956

B BIOTICARE is a trademark filed by Caelus Pharmaceuticals B.V. on July 19, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Caelus Pharmaceuticals B.V. (9 trademarks)

Rondweg 50

Entity Type: 98

Trademark Details

Filing Date

July 19, 2024

Registration Date

Not Registered

Goods & Services

Providing medical and healthcare information in the field of diabetes management, hyperglycemia, cardiovascular health, weight management, metabolic health, and gut health; medical consultation and medical services, namely, telemedicine and remote healthcare by health care professionals via telecommunication networks; Health counselling, health screening services, internet-based health care information services, and medical dietic counseling for the treatment and management of diabetes and metabolic conditions; preparation of reports relating to medical matters, and providing medical diagnostic information to patients and medical practitioners relating to medical information and patient treatment plans; medical testing and analysis for diagnostic purposes; provision of information relating to pharmaceuticals, dietary supplements, and food supplements for diabetes management.

Pharmaceutical products for the prevention and treatment of diabetes, hyperglycemia, hypoglycemia, insulin resistance, cardiovascular diseases, weight management, metabolic syndrome, metabolic imbalances, gastrointestinal disorders, and related endocrine and metabolic health conditions; dietetic foodstuffs and dietetic substances, namely, probiotic supplements, dietary supplements, dietary fibers, functional foods, dietetic foods, dietetic beverages, and nutritional bars adapted for medical use; food supplements and nutritional supplements for human beings; medicinal healthcare preparations for the treatment of diabetes, hyperglycemia, hypoglycemia, insulin resistance, cardiovascular diseases, weight management, metabolic syndrome, metabolic imbalances, gastrointestinal disorders, and related endocrine and metabolic health conditions.

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Feb 26, 2026 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Feb 26, 2026 ABN2
NOTIFICATION OF FINAL REFUSAL EMAILED
Nov 12, 2025 GNFN
FINAL REFUSAL E-MAILED
Nov 12, 2025 GNFR
FINAL REFUSAL WRITTEN
Nov 12, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 15, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 15, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 15, 2025 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
May 15, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
May 15, 2025 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 15, 2025 GNRN
NON-FINAL ACTION E-MAILED
Feb 15, 2025 GNRT
NON-FINAL ACTION WRITTEN
Feb 15, 2025 CNRT
ASSIGNED TO EXAMINER
Feb 13, 2025 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Feb 12, 2025 MDSM
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 12, 2025 NWOS
NEW APPLICATION ENTERED
Jul 19, 2024 NWAP